RSSS vs CODA vs INFU

For growth investors, Coda Octopus Group, Inc.

(CODA) is the stronger pick with 30. 7% revenue growth year-over-year, versus 6. 4% for InfuSystem Holdings, Inc. (INFU). InfuSystem Holdings, Inc. (INFU) offers the better valuation at 28. 9x trailing P/E (19. 8x forward), making it the more compelling value choice. Analysts rate Coda Octopus Group, Inc. (CODA) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, InfuSystem Holdings, Inc.

(INFU) is the cheapest at 28. 9x versus Research Solutions, Inc. at 64. 5x. On forward P/E, InfuSystem Holdings, Inc. is actually cheaper at 19. 8x.

Over the past 5 years, Coda Octopus Group, Inc.

(CODA) delivered a total return of +49. 7%, compared to -57. 0% for InfuSystem Holdings, Inc. (INFU). Over 10 years, the gap is even starker: CODA returned +861. 1% versus INFU's +143. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Research Solutions, Inc.

(RSSS) is the lower-risk stock at 0. 57β versus InfuSystem Holdings, Inc. 's 1. 38β — meaning INFU is approximately 143% more volatile than RSSS relative to the S&P 500. On balance sheet safety, Coda Octopus Group, Inc. (CODA) carries a lower debt/equity ratio of 1% versus 6% for InfuSystem Holdings, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Coda Octopus Group, Inc.

(CODA) is pulling ahead at 30. 7% versus 6. 4% for InfuSystem Holdings, Inc. (INFU). On earnings-per-share growth, the picture is similar: InfuSystem Holdings, Inc. grew EPS 181. 8% year-over-year, compared to 15. 6% for Coda Octopus Group, Inc.. Over a 3-year CAGR, RSSS leads at 14. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Coda Octopus Group, Inc.

(CODA) is the more profitable company, earning 15. 5% net margin versus 2. 6% for Research Solutions, Inc. — meaning it keeps 15. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CODA leads at 17. 1% versus 5. 1% for RSSS. At the gross margin level — before operating expenses — CODA leads at 66. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, InfuSystem Holdings, Inc.

(INFU) trades at 19. 8x forward P/E versus 22. 8x for Coda Octopus Group, Inc. — 3. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for INFU: 67. 4% to $15. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Coda Octopus Group, Inc.

(CODA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 99), +861. 1% 10Y return). Both have compounded well over 10 years (CODA: +861. 1%, INFU: +143. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (RSSS (Technology) and CODA (Industrials) and INFU (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: RSSS is a small-cap quality compounder stock; CODA is a small-cap high-growth stock; INFU is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.